{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:19Z","timestamp":1707525319063},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,11]]},"DOI":"10.7759\/cureus.46866","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:45:59Z","timestamp":1697075159000},"source":"Crossref","is-referenced-by-count":0,"title":["Muco-Obstructive Lung Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Garima","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarth","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhriti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han MK","year":"2010","unstructured":"Han MK, Agusti A, Calverley PM, et al.. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, 182:598-604. 10.1164\/rccm.200912-1843CC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.03.012","article-title":"Characterisation of the onset and presenting clinical features of adult bronchiectasis","volume":"100","author":"King PT","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006, 100:2183-2189. 10.1016\/j.rmed.2006.03.012","journal-title":"Respir Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.04.008","article-title":"Primary ciliary dyskinesia","volume":"37","author":"Knowles MR","year":"2016","unstructured":"Knowles MR, Zariwala M, Leigh M. Primary ciliary dyskinesia. Clin Chest Med. 2016, 37:449-461. 10.1016\/j.ccm.2016.04.008","journal-title":"Clin Chest Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis PB","year":"2006","unstructured":"Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006, 173:475-482. 10.1164\/rccm.200505-840OE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811787115","article-title":"Roles of mucus adhesion and cohesion in cough clearance","volume":"115","author":"Button B","year":"2018","unstructured":"Button B, Goodell HP, Atieh E, et al.. Roles of mucus adhesion and cohesion in cough clearance. Proc Natl Acad Sci U S A. 2018, 115:12501-12506. 10.1073\/pnas.1811787115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1813799","article-title":"Muco-obstructive lung diseases","volume":"380","author":"Boucher RC","year":"2019","unstructured":"Boucher RC. Muco-obstructive lung diseases. N Engl J Med. 2019, 380:1941-1953. 10.1056\/NEJMra1813799","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.63","article-title":"Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease","volume":"10","author":"Livraghi-Butrico A","year":"2017","unstructured":"Livraghi-Butrico A, Grubb BR, Wilkinson KJ, et al.. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease. Mucosal Immunol. 2017, 10:395-407. 10.1038\/mi.2016.63","journal-title":"Mucosal Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch D","year":"2002","unstructured":"Worlitzsch D, Tarran R, Ulrich M, et al.. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002, 109:317-325. 10.1172\/JCI13870","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld M","year":"2001","unstructured":"Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr. 2001, 139:359-365. 10.1067\/mpd.2001.117288","journal-title":"J Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1525OC","article-title":"Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease","volume":"173","author":"Sethi S","year":"2006","unstructured":"Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006, 173:991-998. 10.1164\/rccm.200509-1525OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis","volume":"62","author":"Goss CH","year":"2007","unstructured":"Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis. Thorax. 2007, 62:360-367. 10.1136\/thx.2006.060889","journal-title":"Thorax"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3505","article-title":"Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies","volume":"11","author":"Leung HM","year":"2019","unstructured":"Leung HM, Birket SE, Hyun C, et al.. Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies. Sci Transl Med. 2019, 11:10.1126\/scitranslmed.aav3505","journal-title":"Sci Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73469","article-title":"Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure","volume":"124","author":"Henderson AG","year":"2014","unstructured":"Henderson AG, Ehre C, Button B, et al.. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest. 2014, 124:3047-3060. 10.1172\/JCI73469","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2230OC","article-title":"The relationship of mucus concentration (hydration) to mucus osmotic pressure and transport in chronic bronchitis","volume":"192","author":"Anderson WH","year":"2015","unstructured":"Anderson WH, Coakley RD, Button B, et al.. The relationship of mucus concentration (hydration) to mucus osmotic pressure and transport in chronic bronchitis. Am J Respir Crit Care Med. 2015, 192:182-190. 10.1164\/rccm.201412-2230OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00025.2015","article-title":"The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease","volume":"97","author":"Hogg JC","year":"2017","unstructured":"Hogg JC, Par\u00e9 PD, Hackett TL. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017, 97:529-552. 10.1152\/physrev.00025.2015","journal-title":"Physiol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701632","article-title":"Airway mucin concentration as a marker of chronic bronchitis","volume":"377","author":"Kesimer M","year":"2017","unstructured":"Kesimer M, Ford AA, Ceppe A, et al.. Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017, 377:911-922. 10.1056\/NEJMoa1701632","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1113%2Fjphysiol.2009.186643","article-title":"Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides","volume":"12","author":"Kreda SM","year":"2010","unstructured":"Kreda SM, Seminario-Vidal L, van Heusden CA, O'Neal W, Jones L, Boucher RC, Lazarowski ER. Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol. 2010, 12:2255-2267. 10.1113%2Fjphysiol.2009.186643","journal-title":"J Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S132961","article-title":"Bronchiectasis in COPD patients: more than a comorbidity?","volume":"12","author":"Martinez-Garcia MA","year":"2017","unstructured":"Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity?. Int J Chron Obstruct Pulmon Dis. 2017, 12:1401-1411. 10.2147\/COPD.S132961","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy TF","year":"2008","unstructured":"Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 177:853-860. 10.1164\/rccm.200709-1413OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2015.09.001","article-title":"Genetics and biology of primary ciliary dyskinesia","volume":"18","author":"Horani A","year":"2016","unstructured":"Horani A, Ferkol TW, Dutcher SK, Brody SL. Genetics and biology of primary ciliary dyskinesia. Paediatr Respir Rev. 2016, 18:18-24. 10.1016\/j.prrv.2015.09.001","journal-title":"Paediatr Respir Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1.118","article-title":"Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis","volume":"129","author":"Bush A","year":"2006","unstructured":"Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest. 2006, 129:118-123. 10.1378\/chest.129.1.118","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003755","article-title":"Mechanosensitive ATP release maintains proper mucus hydration of airways","volume":"6","author":"Button B","year":"2013","unstructured":"Button B, Okada SF, Frederick CB, Thelin WR, Boucher RC. Mechanosensitive ATP release maintains proper mucus hydration of airways. Sci Signal. 2013, 6:ra46. 10.1126\/scisignal.2003755","journal-title":"Sci Signal"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume PA","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018, 392:880-890. 10.1016\/S0140-6736(18)31767-7","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/thx.7.3.213","article-title":"A study of the pathology and pathogenesis of bronchiectasis","volume":"7","author":"Whitwell F","year":"1952","unstructured":"Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952, 7:213-239. 10.1136\/thx.7.3.213","journal-title":"Thorax"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.3.198","article-title":"Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests","volume":"55","author":"Roberts HR","year":"2000","unstructured":"Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J, Cole PJ, Hansell DM. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000, 55:198-204. 10.1136\/thorax.55.3.198","journal-title":"Thorax"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170622","article-title":"Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients","volume":"12","author":"Cox MJ","year":"2017","unstructured":"Cox MJ, Turek EM, Hennessy C, et al.. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients. PLoS One. 2017, 12:e0170622. 10.1371\/journal.pone.0170622","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit TR","year":"2017","unstructured":"Aksamit TR, O'Donnell AE, Barker A, et al.. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017, 151:982-992. 10.1016\/j.chest.2016.10.055","journal-title":"Chest"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181","author":"Farrell PM","year":"2017","unstructured":"Farrell PM, White TB, Ren CL, et al.. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr. 2017, 181:S4-S15.e1. 10.1016\/j.jpeds.2016.09.064","journal-title":"J Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey BW","year":"2011","unstructured":"Ramsey BW, Davies J, McElvaney NG, et al.. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011, 365:1663-1672. 10.1056\/NEJMoa1105185","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.04.003","article-title":"Repurposing excipients as active inhalation agents: the mannitol story","volume":"133","author":"Anderson SD","year":"2018","unstructured":"Anderson SD, Daviskas E, Brannan JD, Chan HK. Repurposing excipients as active inhalation agents: the mannitol story. Adv Drug Deliv Rev. 2018, 133:45-56. 10.1016\/j.addr.2018.04.003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson SH","year":"2006","unstructured":"Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006, 354:241-250. 10.1056\/NEJMoa043891","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.09.007","article-title":"The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis","volume":"43","author":"Shei RJ","year":"2018","unstructured":"Shei RJ, Peabody JE, Kaza N, Rowe SM. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis. Curr Opin Pharmacol. 2018, 43:152-165. 10.1016\/j.coph.2018.09.007","journal-title":"Curr Opin Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins MR","year":"2006","unstructured":"Elkins MR, Robinson M, Rose BR, et al.. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006, 354:229-240. 10.1056\/NEJMoa043900","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00047504","article-title":"Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease","volume":"25","author":"Fujimoto K","year":"2005","unstructured":"Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J. 2005, 25:640-646. 10.1183\/09031936.05.00047504","journal-title":"Eur Respir J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1169-9","article-title":"Validation of the IPF-specific version of St. George's Respiratory Questionnaire","volume":"20","author":"Prior TS","year":"2019","unstructured":"Prior TS, Hoyer N, Shaker SB, Davidsen JR, Yorke J, Hilberg O, Bendstrup E. Validation of the IPF-specific version of St. George's Respiratory Questionnaire. Respir Res. 2019, 20:199. 10.1186\/s12931-019-1169-9","journal-title":"Respir Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3488","article-title":"Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis","volume":"11","author":"Esther CR Jr","year":"2019","unstructured":"Esther CR Jr, Muhlebach MS, Ehre C, et al.. Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis. Sci Transl Med. 2019, 11:10.1126\/scitranslmed.aav3488","journal-title":"Sci Transl Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy JV","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010, 363:2233-2247. 10.1056\/NEJMra0910061","journal-title":"N Engl J Med"},{"key":"ref38","unstructured":"Restrictive vs. obstructive lung disease. (2022). Accessed. September 18, 2023: https:\/\/www.webmd.com\/lung\/obstructive-and-restrictive-lung-disease."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183893-muco-obstructive-lung-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:31Z","timestamp":1707509431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183893-muco-obstructive-lung-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.46866","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}